State of the science on prevention and screening to reduce melanoma incidence and mortality

The time is now

Mary K. Tripp, Meg Watson, Sophie J. Balk, Susan M. Swetter, Jeffrey E. Gershenwald

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Answer questions and earn CME/CNE Although overall cancer incidence rates are decreasing, melanoma incidence rates continue to increase about 3% annually. Melanoma is a significant public health problem that exacts a substantial financial burden. Years of potential life lost from melanoma deaths contribute to the social, economic, and human toll of this disease. However, most cases are potentially preventable. Research has clearly established that exposure to ultraviolet radiation increases melanoma risk. Unprecedented antitumor activity and evolving survival benefit from novel targeted therapies and immunotherapies are now available for patients with unresectable and/or metastatic melanoma. Still, prevention (minimizing sun exposure that may result in tanned or sunburned skin and avoiding indoor tanning) and early detection (identifying lesions before they become invasive or at an earlier stage) have significant potential to reduce melanoma incidence and melanoma-associated deaths. This article reviews the state of the science on prevention and early detection of melanoma and current areas of scientific uncertainty and ongoing debate. The US Surgeon General's Call to Action to Prevent Skin Cancer and US Preventive Services Task Force reviews on skin cancer have propelled a national discussion on melanoma prevention and screening that makes this an extraordinary and exciting time for diverse disciplines in multiple sectors-health care, government, education, business, advocacy, and community-to coordinate efforts and leverage existing knowledge to make major strides in reducing the public health burden of melanoma in the United States.

Original languageEnglish (US)
JournalCa-A Cancer Journal for Clinicians
DOIs
StateAccepted/In press - 2016

Fingerprint

Melanoma
Mortality
Incidence
Skin Neoplasms
Public Health
Tanning
Health Care Sector
Solar System
Advisory Committees
Life Expectancy
Immunotherapy
Uncertainty
Economics
Radiation
Education
Skin
Survival
Research

Keywords

  • Indoor tanning
  • Legislation as topic
  • Melanoma/epidemiology
  • Melanoma/prevention and control
  • Public health
  • Sunbathing
  • Suntan
  • Ultraviolet rays/adverse effects
  • US Food and Drug Administration
  • US Preventive Services Task Force

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

State of the science on prevention and screening to reduce melanoma incidence and mortality : The time is now. / Tripp, Mary K.; Watson, Meg; Balk, Sophie J.; Swetter, Susan M.; Gershenwald, Jeffrey E.

In: Ca-A Cancer Journal for Clinicians, 2016.

Research output: Contribution to journalArticle

@article{cc0049affeb54190ac0062b926489915,
title = "State of the science on prevention and screening to reduce melanoma incidence and mortality: The time is now",
abstract = "Answer questions and earn CME/CNE Although overall cancer incidence rates are decreasing, melanoma incidence rates continue to increase about 3{\%} annually. Melanoma is a significant public health problem that exacts a substantial financial burden. Years of potential life lost from melanoma deaths contribute to the social, economic, and human toll of this disease. However, most cases are potentially preventable. Research has clearly established that exposure to ultraviolet radiation increases melanoma risk. Unprecedented antitumor activity and evolving survival benefit from novel targeted therapies and immunotherapies are now available for patients with unresectable and/or metastatic melanoma. Still, prevention (minimizing sun exposure that may result in tanned or sunburned skin and avoiding indoor tanning) and early detection (identifying lesions before they become invasive or at an earlier stage) have significant potential to reduce melanoma incidence and melanoma-associated deaths. This article reviews the state of the science on prevention and early detection of melanoma and current areas of scientific uncertainty and ongoing debate. The US Surgeon General's Call to Action to Prevent Skin Cancer and US Preventive Services Task Force reviews on skin cancer have propelled a national discussion on melanoma prevention and screening that makes this an extraordinary and exciting time for diverse disciplines in multiple sectors-health care, government, education, business, advocacy, and community-to coordinate efforts and leverage existing knowledge to make major strides in reducing the public health burden of melanoma in the United States.",
keywords = "Indoor tanning, Legislation as topic, Melanoma/epidemiology, Melanoma/prevention and control, Public health, Sunbathing, Suntan, Ultraviolet rays/adverse effects, US Food and Drug Administration, US Preventive Services Task Force",
author = "Tripp, {Mary K.} and Meg Watson and Balk, {Sophie J.} and Swetter, {Susan M.} and Gershenwald, {Jeffrey E.}",
year = "2016",
doi = "10.3322/caac.21352",
language = "English (US)",
journal = "Ca-A Cancer Journal for Clinicians",
issn = "0007-9235",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - State of the science on prevention and screening to reduce melanoma incidence and mortality

T2 - The time is now

AU - Tripp, Mary K.

AU - Watson, Meg

AU - Balk, Sophie J.

AU - Swetter, Susan M.

AU - Gershenwald, Jeffrey E.

PY - 2016

Y1 - 2016

N2 - Answer questions and earn CME/CNE Although overall cancer incidence rates are decreasing, melanoma incidence rates continue to increase about 3% annually. Melanoma is a significant public health problem that exacts a substantial financial burden. Years of potential life lost from melanoma deaths contribute to the social, economic, and human toll of this disease. However, most cases are potentially preventable. Research has clearly established that exposure to ultraviolet radiation increases melanoma risk. Unprecedented antitumor activity and evolving survival benefit from novel targeted therapies and immunotherapies are now available for patients with unresectable and/or metastatic melanoma. Still, prevention (minimizing sun exposure that may result in tanned or sunburned skin and avoiding indoor tanning) and early detection (identifying lesions before they become invasive or at an earlier stage) have significant potential to reduce melanoma incidence and melanoma-associated deaths. This article reviews the state of the science on prevention and early detection of melanoma and current areas of scientific uncertainty and ongoing debate. The US Surgeon General's Call to Action to Prevent Skin Cancer and US Preventive Services Task Force reviews on skin cancer have propelled a national discussion on melanoma prevention and screening that makes this an extraordinary and exciting time for diverse disciplines in multiple sectors-health care, government, education, business, advocacy, and community-to coordinate efforts and leverage existing knowledge to make major strides in reducing the public health burden of melanoma in the United States.

AB - Answer questions and earn CME/CNE Although overall cancer incidence rates are decreasing, melanoma incidence rates continue to increase about 3% annually. Melanoma is a significant public health problem that exacts a substantial financial burden. Years of potential life lost from melanoma deaths contribute to the social, economic, and human toll of this disease. However, most cases are potentially preventable. Research has clearly established that exposure to ultraviolet radiation increases melanoma risk. Unprecedented antitumor activity and evolving survival benefit from novel targeted therapies and immunotherapies are now available for patients with unresectable and/or metastatic melanoma. Still, prevention (minimizing sun exposure that may result in tanned or sunburned skin and avoiding indoor tanning) and early detection (identifying lesions before they become invasive or at an earlier stage) have significant potential to reduce melanoma incidence and melanoma-associated deaths. This article reviews the state of the science on prevention and early detection of melanoma and current areas of scientific uncertainty and ongoing debate. The US Surgeon General's Call to Action to Prevent Skin Cancer and US Preventive Services Task Force reviews on skin cancer have propelled a national discussion on melanoma prevention and screening that makes this an extraordinary and exciting time for diverse disciplines in multiple sectors-health care, government, education, business, advocacy, and community-to coordinate efforts and leverage existing knowledge to make major strides in reducing the public health burden of melanoma in the United States.

KW - Indoor tanning

KW - Legislation as topic

KW - Melanoma/epidemiology

KW - Melanoma/prevention and control

KW - Public health

KW - Sunbathing

KW - Suntan

KW - Ultraviolet rays/adverse effects

KW - US Food and Drug Administration

KW - US Preventive Services Task Force

UR - http://www.scopus.com/inward/record.url?scp=84971254254&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84971254254&partnerID=8YFLogxK

U2 - 10.3322/caac.21352

DO - 10.3322/caac.21352

M3 - Article

JO - Ca-A Cancer Journal for Clinicians

JF - Ca-A Cancer Journal for Clinicians

SN - 0007-9235

ER -